Clinical Trial Update: Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation [Phase 4]

View source ↗

Summary

A completed Phase 4 study evaluating tacrolimus as immunosuppressive therapy after kidney transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Kidney Transplantation

Drugs mentioned

• Prograf (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Kidney Transplantation, Kidney Failure, Chronic | Phase 4 | Status: COMPLETED